PAUL V. MAIER
Profile
Related Companies
Titles
Company Name
Related People
DIRECTOR
DIRECTOR
GREGORY BARNHILL, GREGORY H. BARNHILL, DENNIS BROVARONE, ANDREW BUCKLAND, JOHN CARBONE, JOHN J. CARBONE, MD, GARY COHEE, CRAIG C. CULVER, MARK ELLIOTT, CRAIG JOHNSON, MICHAEL KRALL, MICHAEL L. KRALL, HENRY R. LAMBERT, TOM Y. LEE, PAUL MAIER, WILLIAM OTIS, DAVE PFANZELTER, DONNA SINGER, DAVID THENO, JR., PETER C. WULFF
DIRECTOR
DIRECTOR
RICHARD BERMAN, CATHERINE BOVENIZER, EDWARD COX, ROBERTO CREA, MARGARET DALESANDRO, BASSAM B. DAMAJ, BRIAN DORSEY, JUDITH DUNN, HENRY J. ESBER, MICHAEL GOLEMBIEWSKI, BRIAN LIAN, VIVIAN LIU, RAJ MEHRA, NEIL MORTON, DANIEL J. O-CONNOR, LEONARD A OPPENHEIM, LEONARD A. OPPENHEIM, RICHARD W. PASCOE, RUSTY RAY, ROBIN L. SMITH, SANDFORD D. SMITH, MARK WESTGATE, WENDELL WIERENGA, KLEANTHIS G. XANTHOPOULOS
DIRECTOR
JIM J. ANTONOPOULOS, EDWARD W. CANTRALL, KENNETH COHEN, KENNETH M. COHEN, JEFFREY EISENBERG, JEFFREY F. EISENBERG, STEVEN R. GOLDRING, J. DAVID HANSEN, J. DAVID HANSEN, GREGORY HANSON, GREGORY P. HANSON, ROBERT HOFFMAN, WILLIAM P. KAPLAN, PHILIP LIVINGSTON, PHILIP O. LIVINGSTON, PAUL MAFFUID, PAUL W. MAFFUID, PAUL MAIER, RICHARD B. NEWMAN, JEFFREY RAVETCH, JEFFREY V. RAVETCH, PAUL RESNICK, STEVEN R. SCHOW, THOMAS VARRANO, THOMAS VARVARO, THOMAS C. VARVARO, WENDY K. WEE, MICHAEL M. WICK
DIRECTOR
THOMAS ADAMEK, CAMPBELL BECHER, JOHN W. BECK, GRAYDON BENSLER, NOAH DOYLE, MATTHEW W. FOEHR, WILLIAMS LEE, BRAEDEN LICHTI, ROBERT LIM, ROBERT B. LIM, STEVEN MARKOWITZ, WILLIAM M. MERINO, CODY PRICE, KEVIN RICHARDSON II, ANDREW RITTER, ANDREW J. RITTER, IRA RITTER, IRA E. RITTER, MICHAEL D. STEP, MIKE STEP, LEE WILLIAMS
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2018-11-05
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2018-04-30
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2017-09-13
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2012-01-09
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2012-01-09
D
BIOTECHNOLOGY
MISCELLANEOUS CHEMICAL PRODUCTS [2890]
DECLINE TO DISCLOSE
Equity
2010-10-25
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2010-06-07
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2009-10-07

